Young adults taking stimulant medication had significantly improved driving performance on a simulator compared to the placebo group. Also, it was found that there was no significant differences in driving performances between atomoxetine (Strattera, a non-stimulant) and placebo.
ADHD rating scale scores were decreased by at least 30 percent in 80% of the group that took stimulant medication, while the rating scale scores decreased by at least 30 percent in only 40% of the atomoxetine (Strattera) group.
Kay, G. Michaels, M., & Pakull, B. (2009). Simulated Driving Changes in Young Adults With ADHD Receiving Mixed Amphetamine Salts Extended Release and Atomoxetine. Journal of Attention Disorders, 12(4), 316-329.